World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
35177
World Ranking
13929
National Ranking
7069

Daniel W. Lin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Daniel W. Lin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 478 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Daniel W. Lin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel W. Lin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Daniel W. Lin is affiliated with the University of Washington in the United States. Their research primarily focuses on the field of Medicine, with specific subfields including Pulmonary and Respiratory Medicine, Surgery, Oncology, Molecular Biology, and Cancer Research. Within these areas, Lin's work concentrates on topics related to prostate and urinary cancers, cancer metabolism, and health system evaluations.

Lin has contributed extensively to the literature on prostate cancer diagnosis, treatment, and management, reflecting substantial engagement with both clinical and research communities. Their research topics include:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Cancer, Lipids, and Metabolism
  • Urinary and Genital Oncology Studies
  • Global Cancer Incidence and Screening
  • Health Systems, Economic Evaluations, Quality of Life

Lin has published numerous papers in leading journals, with recent publications including:

  • Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management (2022, The Journal of Urology)
  • Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening (2023, The Journal of Urology)
  • Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019 (2020, Journal of Clinical Oncology)
  • Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up (2022, The Journal of Urology)
  • Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy (2023, The Journal of Urology)

The venues where Lin frequently publishes reflect their focus on urologic and oncologic research. These include:

  • The Journal of Urology
  • Journal of Clinical Oncology
  • Urologic Oncology Seminars and Original Investigations
  • European Urology
  • JAMA Oncology

Lin's collaborative work involves multiple frequent coauthors, further supporting interdisciplinary research efforts. Notable coauthors include:

  • Peter S. Nelson
  • Jonathan L. Wright
  • George R. Schade
  • Lisa F. Newcomb
  • Heather H. Cheng

Best Publications

  • Circulating microRNAs as stable blood-based markers for cancer detection

    Patrick S. Mitchell;Rachael K. Parkin;Evan M. Kroh;Brian R. Fritz;Brian R. Fritz

  • Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

    Andrew J. Stephenson;Peter T. Scardino;Michael W. Kattan;Thomas M. Pisansky

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.

    Elahe A. Mostaghel;Stephanie T. Page;Daniel W. Lin;Ladan Fazli

  • Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers

    Gladell P. Paner;Walter M. Stadler;Donna E. Hansel;Rodolfo Montironi

  • A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer

    Dipen J. Parekh;Sanoj Punnen;Daniel D. Sjoberg;Scott W. Asroff

  • Prostate cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

    Mark K. Buyyounouski;Peter L. Choyke;Jesse K. McKenney;Oliver Sartor

  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    David V. Conti;Burcu F. Darst;Lilit C. Moss;Edward J. Saunders

  • Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

    Timothy Gilligan;Daniel W. Lin;Rahul Aggarwal;David Chism

  • Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity

    Stacia K. Wyman;Emily C. Knouf;Emily C. Knouf;Rachael K. Parkin;Brian R. Fritz;Brian R. Fritz

  • A molecular correlate to the Gleason grading system for prostate adenocarcinoma

    Lawrence True;Ilsa Coleman;Sarah Hawley;Ching Ying Huang

  • Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania

    Mauricio Tohen;Ludmila Kryzhanovskaya;Gabrielle Carlson;Melissa DelBello

  • Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

    Mark P. Labrecque;Ilsa M. Coleman;Lisha G. Brown;Lawrence D. True

  • Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer

    John T. Wei;Ziding Feng;Alan W. Partin;Elissa Brown

  • Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline

    Sherri M. Donat;Mireya Diaz;Jay Todd Bishoff;Jonathan A. Coleman

  • Castration-Resistant Prostate Cancer: AUA Guideline

    Michael S. Cookson;Bruce J. Roth;Philipp Dahm;Christine Engstrom

  • Kidney cancer, version 3.2015: Featured updates to the NCCN guidelines

    Robert J. Motzer;Eric Jonasch;Neeraj Agarwal;Clair Beard

  • The role of lineage plasticity in prostate cancer therapy resistance

    Himisha Beltran;Andrew Hruszkewycz;Howard I. Scher;Jeffrey Hildesheim

  • The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy

    Jonathan L. Wright;Daniel W. Lin;Michael P. Porter

  • Kidney cancer, version 1.2021: Featured updates to the nccn guidelines

    Robert J. Motzer;Eric Jonasch;Shawna Boyle;Maria I. Carlo

Frequent Co-Authors

Peter S. Nelson
Peter S. Nelson Fred Hutchinson Cancer Research Center
Janet L. Stanford
Janet L. Stanford Fred Hutchinson Cancer Research Center
Ian M. Thompson
Ian M. Thompson The University of Texas Health Science Center at San Antonio
Lawrence D. True
Lawrence D. True University of Washington
Peter R. Carroll
Peter R. Carroll University of California, San Francisco
Martin E. Gleave
Martin E. Gleave University of British Columbia
James D. Brooks
James D. Brooks Stanford University
Ziding Feng
Ziding Feng Fred Hutchinson Cancer Research Center
Matthew R. Cooperberg
Matthew R. Cooperberg University of California, San Francisco
Adam S. Kibel
Adam S. Kibel Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA can involve a variety of pathways beyond the traditional MD or DO route. Many students choose to start with supporting fields or seek graduate opportunities that allow for greater flexibility and affordability. For example, online healthcare administration programs prepare graduates for vital roles managing medical facilities, without the need for a clinical background.

Pursuing advanced leadership roles? The cheapest mha programs online healthcare provide a cost-effective way to earn a Master's in Health Administration, opening doors to high-level management in hospitals and health systems.

For nurses aiming to move into top clinical or academic roles, the cheapest dnp programs online offer affordable options to achieve a Doctor of Nursing Practice degree. If pharmacy interests you, online pharmacist programs enable you to advance your career with the flexibility of remote study.

Each of these online degrees offers unique career possibilities in the medical field. They provide diverse entry points, making it possible for more students to find rewarding roles in healthcare.

Best Scientists Citing Daniel W. Lin

Trending Scientists